The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
11 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,996,290 in first-year total cost, median $574,360.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IMST-U (55)]6
- Special Emphasis Panel[ZRG1 MCST-U (55)]3
- Special Emphasis Panel[ZRG1 IMST-A (55)]2
Most frequent institutions
- WAKE FOREST UNIVERSITY HEALTH SCIENCES2
- CASE WESTERN RESERVE UNIVERSITY1
- INSTITUTE FOR SYSTEMS BIOLOGY1
- NORTHWESTERN UNIVERSITY1
- UNIVERSITY OF COLORADO DENVER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Translational Combinations of Nanocarriers and Blockers for Metastatic Breast Cancer1R01CA288207-01 | NELSON, ERIK RUSSELLSMITH, ANDREW MICHAEL | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | $570,553 | ZRG1 |
| 2023 | Dual action immunostimulatory nanoparticles for treatment of aggressive cancers1R01CA278633-01 | KARATHANASIS, EFSTATHIOSWANG, LI LILY | CASE WESTERN RESERVE UNIVERSITY, OH | $600,913 | ZRG1 |
| 2023 | Nanodelivery of FP polymers to improve treatment of metastatic colorectal cancer1R01CA284083-01 | GMEINER, WILLIAM H. | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $592,748 | ZRG1 |
| 2023 | Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells1R01CA284065-01 | AKHAVAN, DAVIDBOSSMANN, STEFAN H | UNIVERSITY OF KANSAS MEDICAL CENTER, KS | $574,360 | ZRG1 |
| 2023 | Nanoparticles-mediated combination therapy for breast cancer1R01CA278608-01 | LI, SONG | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $516,189 | ZRG1 |
| 2022 | In situ cancer cell specific biomineralization to overcome nanoparticle delivery barriers and sensitize pancreatic cancer to radiotherapy1R01CA274415-01 | CHO, SANG HYUNKRISHNAN, SUNILSOKOLOV, KONSTANTIN V | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $612,076 | ZRG1 |
| 2022 | Fluorescent Indocarbocyanine PEGylated Lipid Nanoparticles for Understanding and Overcoming Barriers to Drug Delivery in Invasive Glioblastoma1R01CA257958-01A1 | BALYASNIKOVA, IRINA VSIMBERG, DMITRI | UNIVERSITY OF COLORADO DENVER, CO | $588,673 | ZRG1 |
| 2022 | Innovative Research for Cancer Nanotechnology (IRCN) for Enhancing Melanoma-specific Immune Responses by the Rational Design of Spherical Nucleic Acids1R01CA257926-01A1 | MIRKIN, CHAD A.ZHANG, BIN | NORTHWESTERN UNIVERSITY, IL | $521,890 | ZRG1 |
| 2022 | Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma1R01CA263897-01A1 | VIVERO-ESCOTO, JUAN LUIS | UNIVERSITY OF NORTH CAROLINA CHARLOTTE, NC | $349,329 | ZRG1 |
| 2021 | Nano and biomolecular engineered technologies for neoantigen-specific T cell capture and characterization1R01CA264090-01 | HEATH, JAMES R. | INSTITUTE FOR SYSTEMS BIOLOGY, WA | $595,609 | ZRG1 |
| 2021 | Intrapleural immunotherapeutic nanoparticles for MPE treatment1R01CA264102-01 | LU, YONGZHAO, DAWEN | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $473,950 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.